The first data on international multicenter clinical study RheoSTAT-CP0620 on the efficacy and safety of Rheosorbilact® infusion in therapy of sepsis

• Main Authors: V.Kh. Sharipova (Author), S. Beridze (Author), O.O. Pidmurniak (Author), N.A. Shanazarov (Author), Yu.Yu. Kobeliatskyi (Author), V.І. Koshlya (Author), S.B. Peev (Author), N. Babunashvili (Author), V. Cojocaru (Author), A. Bely (Author), O.Ye. Kanikovskyi (Author), I. Pyrtsak (Author)
• Formato: Livro
• Publicado em: Civic Union "Communicable Diseases Intensive Care Association", 2022-05-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Sepsis stays a common and life-threatening pathological condition; hospital mortality in patients with sepsis exceeds 30 %. Fluid resuscitation is an important component of sepsis treatment. The purpose of this work was to evaluate the efficacy and safety of the multicomponent infusion solution Rheo...